Current approved therapeutic strategies for IPF and LC treatment

Targeting metabolic dysregulation for fibrosis therapy

Frontiers Sarcoidosis: Updates on therapeutic drug trials and novel treatment approaches

IJMS, Free Full-Text

Anna SAMARELLI Università degli Studi di Modena e Reggio Emilia

Massimo DOMINICI Università degli Studi di Modena e Reggio

Current approved therapeutic strategies for IPF and LC treatment.

Pulmonary Fibrosis: Unveiling the Pathogenesis, Exploring Therapeutic Targets, and Advancements in Drug Delivery Strategies

Idiopathic pulmonary fibrosis-specific Bayesian network integrating extracellular vesicle proteome and clinical information

Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trial - The Lancet Respiratory Medicine

Dario Andrisani's research works

Giorgia GUAITOLI, Resident